Hepatology
Ademetionine PSK
Registration certificate:
INN:
Ademetionine
Release form:
Lyophilisate for the preparation of a solution for intravenous and intramuscular administration
Therapeutic Area:
Hepatology
Pharmacotherapeutic Group:
Other remedies for the treatment of diseases of the gastrointestinal tract and metabolic disorders, Amino acids and their derivatives
Conditions for dispensing:
On prescription
Packaging:

Indications for Use: Ademetionine PSK is indicated for the treatment of adults aged 18 years and older with:

  • Intrahepatic cholestasis in precirrhotic and cirrhotic conditions, which may be observed in the following diseases:
  • Hepatic steatosis (fatty liver disease)
  • Chronic hepatitis
  • Toxic liver injuries of various etiologies, including alcoholic, viral, and drug-induced (e.g., from antibiotics, antineoplastic, antituberculosis, and antiviral drugs, tricyclic antidepressants, oral contraceptives)
  • Chronic acalculous cholecystitis
  • Cholangitis
  • Liver cirrhosis
  • Encephalopathy, including that associated with hepatic insufficiency (including of alcoholic origin)
  • Intrahepatic cholestasis of pregnancy
  • Symptoms of depression

Prescription Status: Rx only.

CONTRAINDICATIONS APPLY. PLEASE CONSULT A SPECIALIST BEFORE USE.

For the full version of the medical instruction for Ademetionine PSK, please visit the open access website at https://grls.rosminzdrav.ru/Default.aspx


Quality control
at all stages of production